Vitamin D: The Most Important Supplement Most People Get Wrong

At a Glance

The Most Misunderstood Molecule in Medicine

What I tell my patients on the first visit, almost without exception: get your vitamin D level tested. Not because it is trendy. Not because it is the supplement du jour. Because in 30 years of clinical practice at our hospital, treating patients from over 90 countries, I have never seen a single nutrient deficiency more widespread, more consequential, and more poorly managed than vitamin D.

Here is what most physicians get wrong: they think of vitamin D as a bone vitamin. It is not. Vitamin D is a secosteroid hormone. It modulates the expression of over 1,000 human genes — roughly 5% of the entire human genome. It regulates calcium metabolism, yes. But it also governs immune function, inflammatory response, mood, insulin sensitivity, cardiovascular health, and antimicrobial defense. Calling vitamin D “a bone vitamin” is like calling the internet “an email system.” You are describing one function and missing the architecture.

The evidence is not emerging. It is overwhelming. And the gap between what the research shows and what conventional medicine practices is one of the most frustrating failures in modern healthcare.

Vitamin D Is Not a Vitamin

Let me be precise about the biochemistry, because it matters for understanding dosing.

When ultraviolet B radiation hits 7-dehydrocholesterol in your skin, it produces cholecalciferol (vitamin D3). This is not a vitamin — it is a photosynthetic product that your body manufactures, like a hormone. The term “vitamin” is a historical accident.

Cholecalciferol is then hydroxylated in the liver to 25-hydroxyvitamin D (25(OH)D, or calcidiol) — this is what we measure in blood tests. It is then further hydroxylated in the kidneys (and in many other tissues) to 1,25-dihydroxyvitamin D (calcitriol) — the biologically active form that binds to the vitamin D receptor (VDR).

The VDR is found in virtually every tissue in the human body: immune cells, brain, heart, muscle, gut, pancreas, prostate, breast, and bone. This is why vitamin D influences so many systems. It is not a cofactor for calcium absorption. It is a master regulatory hormone.

Beyond Bone Health: What Vitamin D Actually Does

Immune Modulation

This is where the evidence is strongest and most clinically relevant, particularly for the patients I treat.

Vitamin D is essential for both innate and adaptive immune function:

Innate immunity: Vitamin D upregulates the expression of cathelicidin (LL-37) and defensins — antimicrobial peptides that are your body’s first line of defense against bacteria, viruses, and fungi. LL-37 is particularly important: it directly kills pathogens by disrupting their cell membranes, it breaks down bacterial biofilms, and it modulates the inflammatory response to prevent excessive tissue damage.

In patients with chronic infections — Lyme disease, recurrent respiratory infections, chronic sinusitis — I consistently find suboptimal vitamin D levels. When we optimize vitamin D to 60-80 ng/ml, LL-37 production increases measurably, and clinical outcomes improve. This is not a minor effect. LL-37 upregulation may be one of the most important mechanisms by which vitamin D reduces infection susceptibility.

Adaptive immunity: Vitamin D modulates T-cell differentiation, promoting regulatory T-cells (Tregs) that prevent autoimmune overactivation while maintaining the capacity to fight infections. It suppresses Th17 responses (associated with autoimmunity and excessive inflammation) and promotes Th2 and Treg responses that restore immune balance.

This is why vitamin D deficiency is consistently associated with autoimmune conditions — multiple sclerosis, type 1 diabetes, rheumatoid arthritis, inflammatory bowel disease. The epidemiological association is strong, and the mechanistic pathway through VDR-mediated T-cell regulation provides a plausible explanation.

Clinical validation: The VITAL trial (25,871 participants) showed that vitamin D supplementation reduced the risk of autoimmune disease by 22% over 5 years. This was a randomized, placebo-controlled trial published in the BMJ. That is strong evidence.

Mood and Neuropsychiatric Function

The VDR is expressed throughout the brain, particularly in areas associated with mood regulation — the hippocampus, prefrontal cortex, and hypothalamus. Vitamin D influences serotonin synthesis through transcriptional regulation of tryptophan hydroxylase 2 (TPH2), the rate-limiting enzyme for brain serotonin production.

Clinical data consistently shows an association between low vitamin D and depression. A meta-analysis by Anglin et al. (2013) demonstrated that low vitamin D levels were associated with a significantly increased risk of depression. Supplementation trials have shown mixed but generally positive results, particularly when baseline levels were deficient.

In my practice, I see the relationship clearly: patients with serum 25(OH)D below 30 ng/ml frequently report depressive symptoms, brain fog, and fatigue. Optimization to 60-80 ng/ml often produces meaningful improvement — though I am careful to note that vitamin D is not an antidepressant, and mood disorders require comprehensive assessment and treatment.

Metabolic Health

Vitamin D deficiency is associated with insulin resistance, metabolic syndrome, and type 2 diabetes. The mechanism involves VDR-mediated regulation of insulin secretion in pancreatic beta cells and insulin sensitivity in target tissues. Observational data is consistent and strong. Interventional data is more mixed, but recent larger trials (D2d trial) suggest meaningful effects in prediabetic populations.

Cancer Risk Reduction

This is where I must grade the evidence carefully. Observational studies consistently show inverse associations between vitamin D levels and colorectal, breast, prostate, and other cancers. The biological mechanisms are plausible — vitamin D promotes cell differentiation, apoptosis, and anti-proliferative signaling through VDR-mediated gene regulation.

However, the major RCTs (VITAL, ViDA) have shown modest or null effects on cancer incidence as a primary outcome. The nuance matters: post-hoc analyses and studies that account for baseline vitamin D levels and achieved serum concentrations show more promising results. The Lappe et al. (2017) trial found that vitamin D plus calcium reduced all-cancer risk by 30% in postmenopausal women when baseline 25(OH)D was below 30 ng/ml.

My assessment: the evidence supports maintaining optimal vitamin D levels for cancer risk reduction, but it does not support using vitamin D as a cancer treatment. The distinction matters.

The Optimal Level Debate

This is where conventional medicine and the evidence diverge most dramatically.

What Most Labs Say

Standard laboratory reference ranges typically define:

• Deficient: below 20 ng/ml (50 nmol/L)
• Insufficient: 20-29 ng/ml (50-72 nmol/L)
• Sufficient: 30-100 ng/ml (75-250 nmol/L)

What the Evidence Supports

The 30 ng/ml threshold was established primarily based on bone metabolism — the level at which PTH (parathyroid hormone) begins to rise, indicating insufficient calcium absorption. But vitamin D does far more than regulate calcium.

Research consistently suggests that many of vitamin D’s extra-skeletal benefits — immune modulation, mood support, cancer risk reduction — require levels well above 30 ng/ml:

• LL-37 antimicrobial peptide expression reaches optimal levels at approximately 40-60 ng/ml.
• Autoimmune disease risk continues to decrease with levels up to 50-60 ng/ml in epidemiological studies.
• Parathyroid hormone suppression is maximized at approximately 40 ng/ml.
• All-cause mortality in large meta-analyses shows a U-shaped curve with the lowest risk at approximately 40-60 ng/ml.

Based on the totality of evidence and my clinical experience, I target 60-80 ng/ml (150-200 nmol/L) in my patients. This is not arbitrary — it is the range where the preponderance of evidence suggests optimal function across multiple organ systems.

Is this controversial? In some circles, yes. But the Endocrine Society recommends “at least 30 ng/ml,” with their clinical practice guidelines noting that 40-60 ng/ml may be preferred. The Vitamin D Council recommends 40-80 ng/ml. The gap between these recommendations and the “sufficient at 30” threshold used by most primary care physicians is substantial and clinically significant.

Why Most People Are Deficient

In our clinical experience — confirmed by published prevalence data — the majority of patients who walk through our door are vitamin D deficient or insufficient. The reasons are straightforward:

1. Latitude. Anyone living above 35°N latitude (most of Europe, northern United States, Canada) cannot produce adequate vitamin D from sun exposure for 4-6 months of the year. The sun angle is too low for UVB rays to reach the skin effectively.

2. Indoor lifestyle. Even in summer, most people spend 90% of their time indoors. Office workers, hospital patients, children in school — none of them are getting meaningful sun exposure.

3. Sunscreen. SPF 30 blocks approximately 97% of UVB radiation. Sunscreen is important for skin cancer prevention, but it effectively eliminates vitamin D synthesis. This is a genuine public health tension with no perfect solution.

4. Skin pigmentation. Melanin is a natural sunscreen. People with darker skin require 3-5 times more sun exposure to produce the same amount of vitamin D as people with lighter skin. This is a significant factor in the disproportionate vitamin D deficiency seen in dark-skinned populations living at high latitudes.

5. Age. The capacity for cutaneous vitamin D synthesis declines with age. A 70-year-old produces approximately 25% of the vitamin D that a 20-year-old produces from the same sun exposure.

6. Obesity. Vitamin D is fat-soluble and sequesters in adipose tissue. People with higher body fat require substantially more vitamin D to achieve the same serum levels. This is clinically important and frequently overlooked in dosing.

7. Dietary inadequacy. Natural dietary sources of vitamin D are limited: fatty fish, egg yolks, liver. Fortified foods provide modest amounts (typically 400 IU per serving). It is virtually impossible to achieve optimal levels through diet alone.

Dosing: The Evidence-Based Approach

The Body Weight Principle

This is a point most physicians and most supplement labels get wrong. Vitamin D dosing should be based on body weight, not on a one-size-fits-all recommendation.

The Endocrine Society’s clinical practice guideline recommends:

• Adults with deficiency: 6,000 IU daily for 8 weeks to achieve levels above 30 ng/ml, then 1,500-2,000 IU daily for maintenance.
• Obese adults: 2-3x the standard dose.

In my practice, I use a more nuanced approach based on published pharmacokinetic data:

These doses are higher than the RDA (600-800 IU), which was established to prevent rickets — not to achieve optimal serum levels. The RDA is a minimum to prevent deficiency disease, not a target for health optimization.

Form Matters

Vitamin D3 (cholecalciferol) is significantly more effective than D2 (ergocalciferol) at raising and maintaining serum 25(OH)D levels. Always use D3. This is settled science.

Vitamin D should be taken with a fat-containing meal for optimal absorption (it is fat-soluble). Taking it on an empty stomach reduces absorption by approximately 50%.

Testing Frequency

At minimum, test 25(OH)D twice yearly:

• Once in late winter (February-March) when levels are lowest
• Once in late summer (August-September) when levels are highest

This gives you your trough and peak. Adjust dosing so your trough does not drop below 50 ng/ml. For patients beginning supplementation or adjusting doses, I test every 8-12 weeks until stable.

The Cofactors: K2 and Magnesium

This is where most vitamin D supplementation protocols fail. Vitamin D does not work in isolation. It requires cofactors, and the two most important are vitamin K2 and magnesium.

Vitamin K2 (Menaquinone-7)

Vitamin D increases intestinal calcium absorption. Without adequate vitamin K2, that calcium can deposit in soft tissues — arterial walls, kidneys, joints — rather than being directed to bone.

Vitamin K2 activates two critical proteins:

• Osteocalcin — directs calcium into bone matrix.
• Matrix Gla Protein (MGP) — prevents calcium deposition in soft tissue and arterial walls.

Without K2, high-dose vitamin D supplementation could theoretically increase cardiovascular calcification risk. With K2, calcium goes where it should (bone) and stays out of where it should not (arteries).

Dosing: 100-200 mcg of MK-7 daily when taking vitamin D. The MK-7 form has the longest half-life and most consistent evidence.

Magnesium

Magnesium is required for the enzymatic conversion of vitamin D to its active form. Specifically:

• The liver enzyme CYP2R1, which converts D3 to 25(OH)D, is magnesium-dependent.
• The kidney enzyme CYP27B1, which converts 25(OH)D to active 1,25(OH)2D, is magnesium-dependent.

If you are magnesium-deficient — and most people are (see our comprehensive magnesium guide) — your body cannot efficiently activate the vitamin D you are taking. This is one reason why some patients supplement vitamin D without seeing their serum levels rise proportionally.

Dosing: 200-400 mg of elemental magnesium daily (glycinate or threonate form preferred — see our magnesium article for why).

Safety and Toxicity

Vitamin D toxicity is real but rare and requires sustained intake well above therapeutic doses. The primary concern is hypercalcemia — elevated blood calcium — which can cause nausea, kidney stones, cardiac arrhythmias, and in severe cases, renal failure.

Key safety points:

• Toxicity typically occurs at serum levels above 150 ng/ml sustained over time. Our target of 60-80 ng/ml has a substantial safety margin.
• The lowest observed adverse effect level (LOAEL) in published case reports is generally associated with daily intakes exceeding 40,000 IU for extended periods, or single massive doses.
• At doses of 4,000-10,000 IU daily, toxicity is exceedingly rare in adults when K2 and magnesium cofactors are provided. The Endocrine Society states that up to 10,000 IU daily is safe for most adults.
• Monitoring is essential. Test 25(OH)D and serum calcium periodically, particularly when initiating high-dose supplementation.
• Certain conditions increase risk: granulomatous diseases (sarcoidosis), lymphoma, and primary hyperparathyroidism can cause abnormal vitamin D metabolism and increased hypercalcemia risk. These patients need closer monitoring.

Who Needs the Most Attention?

Based on published data and clinical experience, the following populations are at highest risk for significant deficiency and stand to benefit most from optimization:

• Chronic infection patients (Lyme, post-COVID, recurrent infections) — immune function depends on adequate vitamin D for LL-37 production and T-cell regulation
• Autoimmune patients — the VITAL trial showed a 22% reduction in autoimmune disease with supplementation
• People with darker skin at high latitudes — up to 80% deficiency rates in some populations
• Obese individuals — require 2-3x standard doses due to adipose sequestration
• Elderly adults — reduced synthesis capacity, increased fall and fracture risk
• Patients on medications that deplete vitamin D — anticonvulsants, glucocorticoids, rifampin, cholestyramine
• Anyone living above 35°N latitude — that includes most of Europe and the northern United States

The Bottom Line

Vitamin D is not a trend. It is a hormone that most humans are deficient in due to the mismatch between our biology (designed for equatorial sun exposure) and our lifestyle (indoor, high-latitude, sunscreen-protected). The evidence for its role in immune function, mood, metabolic health, and disease prevention is strong — supported by large randomized trials, comprehensive meta-analyses, and decades of mechanistic research.

Optimal levels are 60-80 ng/ml, not the conventional “sufficient at 30.” Dosing should be based on body weight. Cofactors K2 and magnesium are non-negotiable. Testing twice yearly is the minimum.

In my clinical practice, vitamin D optimization is the first thing I address in nearly every patient. It is inexpensive, safe at appropriate doses, well-studied, and the single most impactful supplement for the greatest number of people. Get tested. Get your level to 60-80 ng/ml. Take your K2 and magnesium. This is not complicated medicine — it is foundational medicine that most of the medical profession is failing to implement.

References

1. Hahn J, et al. Vitamin D and marine omega 3 fatty acid supplementation and incident autoimmune disease: VITAL randomized controlled trial. BMJ. 2022;376:e066452. PMID: 35082139.

2. Anglin RE, et al. Vitamin D deficiency and depression in adults: systematic review and meta-analysis. Br J Psychiatry. 2013;202:100-107. PMID: 23377209.

3. Holick MF, et al. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2011;96(7):1911-1930. PMID: 21646368.

4. Wang TT, et al. Cutting edge: 1,25-dihydroxyvitamin D3 is a direct inducer of antimicrobial peptide gene expression. J Immunol. 2004;173(5):2909-2912. PMID: 15322146.

5. Lappe J, et al. Effect of vitamin D and calcium supplementation on cancer incidence in older women: a randomized clinical trial. JAMA. 2017;317(12):1234-1243. PMID: 28350929.

6. Autier P, et al. Vitamin D status and ill health: a systematic review. Lancet Diabetes Endocrinol. 2014;2(1):76-89. PMID: 24622671.

This content is educational and does not constitute medical advice. Vitamin D supplementation at doses above the RDA should be monitored with periodic blood testing. Consult a qualified physician before initiating high-dose vitamin D supplementation, particularly if you have kidney disease, granulomatous disease, or are taking medications that affect calcium metabolism.